NCCN Guidelines for Patients® Immunotherapy Side Effects: CAR T-Cell and Lymphocyte Engager Therapy by National Comprehensive Cancer Network® (NCCN®)

[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Immunotherapy Side Effects: CAR T-Cell and Lymphocyte Engager Therapy . Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: Chapter 1 About CAR T-cell and lymphocyte engager therapies, Chapter 2 Side effects of CAR T-cell therapy, Chapter 3 Side effects of anti-BCMA CAR T-cell therapy, Chapter 4 Side effects of lymphocyte engager therapy, Chapter 5 Cytokine release syndrome, Chapter 6 What is ICANS?, Chapter 7 Other resources, Words to know, NCCN Contributors, NCCN Cancer Centers, Index.